Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,448 | 1,134 | 99.2% |
| Education | $174.67 | 5 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,977 | 116 | $0 (2024) |
| ABBVIE INC. | $2,024 | 129 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,132 | 69 | $0 (2024) |
| Amgen Inc. | $1,118 | 50 | $0 (2024) |
| PFIZER INC. | $1,053 | 107 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $1,005 | 42 | $0 (2024) |
| Allergan, Inc. | $911.79 | 63 | $0 (2021) |
| Lilly USA, LLC | $850.71 | 72 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $553.19 | 23 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $468.49 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,221 | 153 | AstraZeneca Pharmaceuticals LP ($582.48) |
| 2023 | $3,389 | 178 | AbbVie Inc. ($586.37) |
| 2022 | $3,269 | 178 | ABBVIE INC. ($634.91) |
| 2021 | $2,637 | 150 | AstraZeneca Pharmaceuticals LP ($534.87) |
| 2020 | $1,849 | 116 | AstraZeneca Pharmaceuticals LP ($332.30) |
| 2019 | $2,191 | 121 | AstraZeneca Pharmaceuticals LP ($333.60) |
| 2018 | $2,055 | 110 | AstraZeneca Pharmaceuticals LP ($336.48) |
| 2017 | $2,013 | 133 | PFIZER INC. ($327.11) |
All Payment Transactions
1,139 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: UROLOGY | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Respiratory | ||||||
| 12/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Cardio-renal | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: DIABETES | ||||||
| 12/04/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Endocrinology | ||||||
| 12/04/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $1.03 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: Biological | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.19 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: DIABETES | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $0.43 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.95 | General |
| 10/25/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: UROLOGY | ||||||
| 10/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 80 | 8,273 | 14,348 | $824,934 | $333,993 |
| 2022 | 78 | 7,387 | 12,325 | $782,917 | $329,524 |
| 2021 | 80 | 6,283 | 10,629 | $642,917 | $284,258 |
| 2020 | 64 | 4,707 | 8,099 | $513,141 | $250,876 |
All Medicare Procedures & Services
309 procedure records from CMS Medicare Utilization — Page 1 of 13
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 545 | 1,360 | $197,220 | $60,663 | 30.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 161 | 1,105 | $103,870 | $57,651 | 55.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 15 | 1,140 | $28,200 | $21,066 | 74.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 291 | 370 | $36,260 | $16,328 | 45.0% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 116 | 157 | $27,475 | $15,231 | 55.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 311 | 311 | $51,315 | $13,602 | 26.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 36 | 36 | $10,800 | $10,145 | 93.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 635 | 974 | $24,350 | $9,984 | 41.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 490 | 599 | $23,960 | $9,860 | 41.2% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 44 | 167 | $15,698 | $8,178 | 52.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 534 | 605 | $18,150 | $7,924 | 43.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 103 | 103 | $8,034 | $7,409 | 92.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 629 | 894 | $16,986 | $6,750 | 39.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 449 | 787 | $10,231 | $6,611 | 64.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 320 | 320 | $8,960 | $5,181 | 57.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 161 | 165 | $6,270 | $4,592 | 73.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 235 | 474 | $12,324 | $4,484 | 36.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 219 | 219 | $6,132 | $3,531 | 57.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 52 | $4,892 | $2,980 | 60.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 89 | 98 | $4,802 | $2,826 | 58.9% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 39 | 99 | $6,237 | $2,807 | 45.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 18 | 82 | $16,400 | $2,743 | 16.7% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 106 | 106 | $4,028 | $2,462 | 61.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 100 | 277 | $11,911 | $2,400 | 20.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 302 | 302 | $37,750 | $2,357 | 6.2% |
About Dr. Hunter Carrington, M.D
Dr. Hunter Carrington, M.D is a Family Medicine healthcare provider based in Hot Springs, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2010. The National Provider Identifier (NPI) number assigned to this provider is 1992016638.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hunter Carrington, M.D has received a total of $20,623 in payments from pharmaceutical and medical device companies, with $3,221 received in 2024. These payments were reported across 1,139 transactions from 71 companies. The most common payment nature is "Food and Beverage" ($20,448).
As a Medicare-enrolled provider, Carrington has provided services to 26,650 Medicare beneficiaries, totaling 45,401 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 309 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Hot Springs, AR
- Active Since 06/28/2010
- Last Updated 04/18/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1992016638
Products in Payments
- FARXIGA (Drug) $1,747
- VRAYLAR (Drug) $1,345
- TRELEGY ELLIPTA (Drug) $725.52
- UBRELVY (Drug) $590.24
- XARELTO (Drug) $504.94
- REXULTI (Drug) $501.43
- LINZESS (Drug) $458.98
- JARDIANCE (Drug) $456.56
- Kerendia (Drug) $443.66
- Auvelity (Drug) $419.92
- Repatha (Biological) $375.35
- BREZTRI (Drug) $363.36
- CAPLYTA (Drug) $358.57
- AIRSUPRA (Drug) $349.32
- Otezla (Drug) $334.52
- QULIPTA (Drug) $333.54
- ENTRESTO (Drug) $324.10
- NURTEC ODT (Drug) $298.05
- XIFAXAN (Drug) $263.67
- SPRAVATO (Drug) $259.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hot Springs
Anna Parchman, Md, MD
Family Medicine — Payments: $20,017
Scott Anderson, D.o, D.O
Family Medicine — Payments: $13,513
Robert Parrott, D.o, D.O
Family Medicine — Payments: $12,791
Dr. Martin Koehn, M.d, M.D
Family Medicine — Payments: $11,985
Jodi Sanson, Md, MD
Family Medicine — Payments: $9,880
Dr. Halah Al-Dadah, M.d, M.D
Family Medicine — Payments: $9,774